Login
Subscribe
New Drug Combo for ALS Slows Decline in Small Clinical Study
New Drug Combo for ALS Slows Decline in Small Clinical Study
After six months, patients with fast-progressing amyotrophic lateral sclerosis who had received the experimental treatment had less loss of function than those who received a placebo.
After six months, patients with fast-progressing amyotrophic lateral sclerosis who had received the experimental treatment had less loss of function than those who received a placebo.
ALS, disease & medicine, neuroscience
Breaking Down Barriers
The Scientist | Oct 19, 2020 | 1 min read
Looking at the future of neurodegeneration research!
Commensal Bacterium Reduces ALS Symptoms in Mice
Jef Akst | Jul 24, 2019 | 2 min read
Boosting the levels of Akkermansia muciniphila in mouse guts slowed the progression of an ALS-like disease, while two other microbiome members were associated with more severe symptoms.